Motley Fool Money cover image

Show Business is Back in Business!

Motley Fool Money

00:00

Exploring New Investment Opportunities and weight loss Pharmaceuticals

This chapter explores a forthcoming book on wealth generation and promotes a special discount on an investment service. It also delves into the implications of the FDA's approval of Eli Lilly's weight loss drug ZepBound, considering its potential effects on the market and business strategies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app